Main Profile

At A Glance

Targeted drug helps Hodgkin lymphoma patients

An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report in the Nov. 4 issue of the New England Journal of Medicine.
Length: 02:06

Contact

Questions about Targeted drug helps Hodgkin lymphoma patients

Want more info about Targeted drug helps Hodgkin lymphoma patients? Get free advice from education experts and Noodle community members.

  • Answer

Ask a New Question